Wall Street Analysts See a 27.35% Upside in Harmony Biosciences (HRMY): Can the Stock Really Move This High?

Analysts’ average price target for Harmony Biosciences implies 27.4% upside. The article notes that while price-target “mean” is not always reliable, analysts are showing strong agreement and lifting earnings estimates, signaling incremental bullish sentiment for HRMY.

Analysis

Analysts’ average price target for Harmony Biosciences implies 27.4% upside. The article notes that while price-target “mean” is not always reliable, analysts are showing strong agreement and lifting earnings estimates, signaling incremental bullish sentiment for HRMY.